Showing 8531-8540 of 19300 results for "".
- GLP-1RAs Linked with Reduced Itch Prevalence in Diabetes Cohorthttps://reachmd.com/news/glp-1-receptor-agonists-tied-to-reduced-itch-prevalence-in-diabetes-cohort/2485184/Results from a new retrospective cohort analysis suggest some glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a reduced prevalence of itch the type 2 diabetes mellitus (T2DM), independent of glycemic control.
- Inflammatory Diets During Pregnancy Linked to Higher Offspring Diabetes Riskhttps://reachmd.com/news/inflammatory-diets-during-pregnancy-linked-to-higher-offspring-diabetes-risk/2475490/A recent Danish cohort analysis indicates an association between maternal diets high in inflammatory foods and an increased risk of type 1 diabetes in offspring, suggesting a need to reevaluate prenatal nutritional guidance. According
- Lifestyle Interventions and Diabetes Prevention: Planning, Tracking, and Mindful Livinghttps://reachmd.com/news/lifestyle-interventions-and-diabetes-prevention-planning-tracking-and-mindful-living/2474656/Comprehensive lifestyle interventions incorporating strategic planning, progress tracking, and mindfulness are significantly reducing the risk of type 2 diabetes. With evidence indicating that nearly 38% of U.S. adults are affected by
- Exploring the Ocular Benefits of GLP-1 Receptor Agonists in Type 2 Diabetes Managementhttps://reachmd.com/news/exploring-the-ocular-benefits-of-glp-1-receptor-agonists-in-type-2-diabetes-management/2471688/GLP-1 Receptor Agonists: A Novel Protective Agent Against Glaucoma in Diabetic Patients? Recent investigations have highlighted that beyond their well-known effects on glycemic control, GLP-1 receptor agonists may significantly reduce the risk of developing primary
- Study: Test Improves the Risk Stratification of Patients with Stage I Melanomahttps://reachmd.com/news/study-finds-decisiondx-melanoma-significantly-improves-the-risk-stratification-of-patients-with-stage-i-melanoma-compared-to-american-joint-committee-on-cancer-8th-edition-staging/2462252/Results from a recent study showed the potential of a 31-gene expression profile (31-GEP) test in improving the prognosis for patients diagnosed with stage I cutaneous melanoma. Despite being considered at low risk for metastasis or melanoma-specific death, patients with stage I cutaneous
- Achieving Optimal Cardiovascular Health to Reduce Dementia Risk in Type 2 Diabeteshttps://reachmd.com/news/achieving-optimal-cardiovascular-health-to-reduce-dementia-risk-in-type-2-diabetes/2484364/A preliminary study being presented at the American Heart Association (AHA) Scientific Sessions suggests that amon
- Meat Consumption Significantly Raises Type 2 Diabetes Riskhttps://reachmd.com/news/meat-consumption-significantly-raises-type-2-diabetes-risk/2467973/Study:
- Rheumatoid Arthritis Drug Shows Promise as Type 1 Diabetes Treatmenthttps://reachmd.com/news/rheumatoid-arthritis-drug-shows-promise-as-type-1-diabetes-treatment/2457135/
- Revolutionizing Diabetic Kidney Disease Care with Predictive Biomarkershttps://reachmd.com/news/revolutionizing-diabetic-kidney-disease-care-with-predictive-biomarkers/2475945/More than one-third of individuals with type 2 diabetes will develop chronic kidney disease before symptoms emerge, demanding a paradigm shift toward predictive biomarker–guided care. Diabetes-induced chronic kidney disease advances asymptomatically, often eluding detection until glo
- Innovations in Personalized Cancer Therapy: Insights from the I-PREDICT Trialhttps://reachmd.com/news/innovations-in-personalized-cancer-therapy-insights-from-the-i-predict-trial/2485275/The I-PREDICT trial shows tumor-DNA personalization of multi-drug regimens improves response and survival without increasing severe toxicity—a clin